Gilead’s Kite to Collaborate with Shoreline for CAR NK Therapies

By Shikha Kashyap

Pharma Deals Review: Vol 2021 Issue 7 (Table of Contents)

Published: 27 Jul-2021

DOI: 10.3833/pdr.v2021.i7.2628     ISSN: 1756-7874

Section: Research & Development



In a move to bolster its cell therapies offering, Kite Pharma, a Gilead company agreed to collaborate with Shoreline Biosciences to develop novel cell therapies across a variety of cancer targets...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details